Retraction Note: ERK1/2-Nanog signaling pathway enhances CD44(+) cancer stem-like cell phenotypes and epithelial-to-mesenchymal transition in head and neck squamous cell carcinomas

Cell Death & Disease, Published online: 15 March 2024; doi:10.1038/s41419-024-06608-7Retraction Note: ERK1/2-Nanog signaling pathway enhances CD44(+) cancer stem-like cell phenotypes and epithelial-to-mesenchymal transition in head and neck squamous cell carcinomas
Source: Cell death and disease - Category: Internal Medicine Authors: Source Type: research